| Dr Julie C Haviland, MD | |
|
364 White Oak St, Asheboro, NC 27203 | |
| (336) 629-8807 | |
| Not Available |
| Full Name | Dr Julie C Haviland |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 364 White Oak St, Asheboro, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568557122 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Moses H. Cone Memorial Hospital, The | Greensboro, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wake Forest Emergency Providers | 7012819816 | 218 |
News Archive
MicroDose Therapeutx Inc. today announced that it has acquired a portfolio of compounds for the potential treatment of chronic constipation, irritable bowel syndrome with constipation (IBS-C) and other diseases, from Epix Pharmaceuticals, Inc. (EPIX) (Lexington, MA).
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.
Being able to understand speech is essential to our evolution as humans. Hearing lets us perceive the same word even when spoken at different speeds or pitches, and also gives us extra sensitivity to unexpected sounds. Now, new studies from the Perelman School of Medicine at the University of Pennsylvania clarify how these two crucial features of audition are managed by the brain.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 6 days ago
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
MicroDose Therapeutx Inc. today announced that it has acquired a portfolio of compounds for the potential treatment of chronic constipation, irritable bowel syndrome with constipation (IBS-C) and other diseases, from Epix Pharmaceuticals, Inc. (EPIX) (Lexington, MA).
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.
Being able to understand speech is essential to our evolution as humans. Hearing lets us perceive the same word even when spoken at different speeds or pitches, and also gives us extra sensitivity to unexpected sounds. Now, new studies from the Perelman School of Medicine at the University of Pennsylvania clarify how these two crucial features of audition are managed by the brain.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 6 days ago
| Entity Name | Asheboro Emergency Physicians Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689779720 PECOS PAC ID: 3476532920 Enrollment ID: O20040717000225 |
News Archive
MicroDose Therapeutx Inc. today announced that it has acquired a portfolio of compounds for the potential treatment of chronic constipation, irritable bowel syndrome with constipation (IBS-C) and other diseases, from Epix Pharmaceuticals, Inc. (EPIX) (Lexington, MA).
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.
Being able to understand speech is essential to our evolution as humans. Hearing lets us perceive the same word even when spoken at different speeds or pitches, and also gives us extra sensitivity to unexpected sounds. Now, new studies from the Perelman School of Medicine at the University of Pennsylvania clarify how these two crucial features of audition are managed by the brain.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 6 days ago
| Entity Name | Wake Forest Emergency Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396216735 PECOS PAC ID: 7012819816 Enrollment ID: O20190312003619 |
News Archive
MicroDose Therapeutx Inc. today announced that it has acquired a portfolio of compounds for the potential treatment of chronic constipation, irritable bowel syndrome with constipation (IBS-C) and other diseases, from Epix Pharmaceuticals, Inc. (EPIX) (Lexington, MA).
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.
Being able to understand speech is essential to our evolution as humans. Hearing lets us perceive the same word even when spoken at different speeds or pitches, and also gives us extra sensitivity to unexpected sounds. Now, new studies from the Perelman School of Medicine at the University of Pennsylvania clarify how these two crucial features of audition are managed by the brain.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julie C Haviland, MD Po Box 1509, Desoto, TX 75123-1509 Ph: (972) 274-1696 | Dr Julie C Haviland, MD 364 White Oak St, Asheboro, NC 27203 Ph: (336) 629-8807 |
News Archive
MicroDose Therapeutx Inc. today announced that it has acquired a portfolio of compounds for the potential treatment of chronic constipation, irritable bowel syndrome with constipation (IBS-C) and other diseases, from Epix Pharmaceuticals, Inc. (EPIX) (Lexington, MA).
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.
Being able to understand speech is essential to our evolution as humans. Hearing lets us perceive the same word even when spoken at different speeds or pitches, and also gives us extra sensitivity to unexpected sounds. Now, new studies from the Perelman School of Medicine at the University of Pennsylvania clarify how these two crucial features of audition are managed by the brain.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 6 days ago
Cameron Loquist, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 138 Dublin Square Rd Ste A, Asheboro, NC 27203 Phone: 336-626-2688 | |
Dr. Mark Robert Keller, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 197 Nc Highway 42 N Ste B, Asheboro, NC 27203 Phone: 336-625-2560 | |
Noralea Elizabeth Meiki Rose, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 364 White Oak St, Asheboro, NC 27203 Phone: 336-629-8807 | |
Dr. Jody N Osborne, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 364 White Oak St, Asheboro, NC 27203 Phone: 336-629-8807 | |
Dr. Samuel Christian Keith, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 364 White Oak St, Asheboro, NC 27203 Phone: 336-625-5151 | |
Robert L. Brown, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 197b Nc Hwy 42n, Asheboro, NC 27203 Phone: 336-625-2560 Fax: 336-625-3152 |